Open access
Aug 2026
Dysferlin is a novel regulator of COMP-positive matrifibrocytes in heart failure
Dysferlin is a stress-inducible antifibrotic regulator that limits maladaptive fibroblast differentiation and myocardial fibrosis, thereby representing a potential therapeutic target to attenuate adverse cardiac remodelling in HF.
I. Kocherova, Muriel Giger, A. Laimbacher et al.
· bioRxiv · 0 citations